Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.70
Delayed Data
As of May 26
 -0.05 / -1.82%
Today’s Change
2.12
Today|||52-Week Range
5.29
-18.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues2.7M3.4M4.1M3.7M
 
 
 
 
 
Cost of Goods Sold452.0K535.0K792.0K570.0K
 
 
 
 
 
Depreciation And Amortization27.0K31.0K16.0K18.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.2M2.9M3.3M3.1M
 
 
 
 
 
General Expenses4.4M5.1M5.3M6.9M
 
 
 
 
 
Research And Development278.0K236.0K156.0K62.0K
 
 
 
 
 
Total Operating Expenses4.9M5.6M6.1M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.2M-2.0M-3.8M
 
 
 
 
 
Extraordinary Credit0.000.00381.0K--
 
 
Extraordinary Charge-424.0K-1.7M---235.0K
 
 
 
 
Other Expenses-59.0K180.0K1.0K2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-3.7M-1.6M-4.0M
 
 
 
 
 
Income Taxes-2.0K0.000.00-1.0K
 
 
 
Net Income-2.7M-3.7M-1.6M-4.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.4M10.9M15.1M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted7.4M10.9M15.5M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.34-$0.13-$0.26
 
 
 
 
 
EPS Diluted-$0.36-$0.34-$0.11-$0.26